Dashyant Dhanak
Chief Tech/Sci/R&D Officer bei DECIPHERA PHARMACEUTICALS, INC.
Vermögen: 6 Mio $ am 31.03.2024
Profil
Zurzeit ist Dashyant Dhanak Chief Scientific Officer & Executive VP bei Incyte Corp. In der Vergangenheit war er Vice President bei GlaxoSmithKline LLC und Vice President & Head-Discovery Sciences bei Janssen Research & Development LLC. Er erhielt einen Bachelor-Abschluss von der University of Manchester Institute of Science & Technology und einen Doktortitel von der University of London.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INCYTE CORPORATION
0,03% | 14.07.2023 | 58 968 ( 0,03% ) | 3 Mio $ | 31.03.2024 |
| 15.02.2024 | 158 175 ( 0,20% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Dashyant Dhanak
| Unternehmen | Position | Beginn |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 05.09.2023 |
Ehemalige bekannte Positionen von Dashyant Dhanak
| Unternehmen | Position | Ende |
|---|---|---|
Janssen Research & Development LLC
 Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Corporate Officer/Principal | 01.11.2018 |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Corporate Officer/Principal | - |
| INCYTE CORPORATION | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Dashyant Dhanak
| University of London | Doctorate Degree |
| University of Manchester Institute of Science & Technology | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| DECIPHERA PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
GlaxoSmithKline LLC
GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Health Technology |
Janssen Research & Development LLC
Janssen Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Part of Johnson & Johnson, Janssen Research & Development LLC is a private company that provides research and development medicines and solutions to other medical needs. The company is based in Raritan, NJ. | Commercial Services |
